205
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Absence of Minimal Residual Disease Detectable by Facs, Southern Blot or PCR in Patients with Chronic Lymphocytic Leukaemia Treated with Fludarabine

, , , &
Pages 627-630 | Received 13 Sep 1993, Accepted 08 Mar 1994, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gavin Cull, Deborah S. Richardson, Denise J. Howe, John A. Hopkins, Stephen A. Johnson & Malcolm J. Phillips. (1995) Molecular Complete Response in a Patient with Chronic Lymphocytic Leukaemia Treated with 2-Chlorodeoxyadenosine. Acta Oncologica 34:4, pages 536-537.
Read now

Articles from other publishers (9)

Paolo Ghia & Andy Rawstron. (2018) Minimal residual disease analysis in chronic lymphocytic leukemia: a way for achieving more personalized treatments. Leukemia 32:6, pages 1307-1316.
Crossref
Donald W. MilliganSavio FernandesRanjit DasguptaFaith E. DaviesEstella MatutesChristopher D. FeganChristopher McConkeyJ. Anthony ChildDavid CunninghamGareth J. MorganDaniel Catovsky. (2005) Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses. Blood 105:1, pages 397-404.
Crossref
Vincent Levy, Raphaël Porcher, Fabrice Delabarre, Michel Leporrier, Bruno Cazin & Sylvie Chevret. (2001) Evaluating treatment strategies in chronic lymphocytic leukemia. Journal of Clinical Epidemiology 54:7, pages 747-754.
Crossref
Clemens-Martin Wendtner, Barbara Schmitt, Manuela Bergmann, Tim Röhnisch, Raymund Buhmann & Michael Hallek. (2001) New aspects on the pathogenesis, diagnostic procedures, and therapeutic management of chronic lymphocytic leukemia. International Journal of Hematology 73:1, pages 32-38.
Crossref
Andrew G. Bosanquet, Stephen A. Johnson & Sue M. Richards. (2001) Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay . British Journal of Haematology 106:1, pages 71-77.
Crossref
M.J. KeatingS. O’BrienS. LernerC. KollerM. BeranL.E. RobertsonE. J FreireichE. EsteyH. Kantarjian. (1998) Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy. Blood 92:4, pages 1165-1171.
Crossref
M.J. KeatingS. O’BrienS. LernerC. KollerM. BeranL.E. RobertsonE. J FreireichE. EsteyH. Kantarjian. (1998) Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy. Blood 92:4, pages 1165-1171.
Crossref
Andrew G. Bosanquet & Philip B. Bell. (1996) Enhanced Ex vivo drug sensitivity testing of chronic lymphocytic leukaemia using refined DiSC assay methodology. Leukemia Research 20:2, pages 143-153.
Crossref
S.A. Johnson. (1996) Purine analogues in the management of lymphoproliferative diseases. Clinical Oncology 8:5, pages 289-296.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.